Wikipedia -WSS

Wikipedia

author：knowledge 2025-09-29 17:02:15 - browse：774

Eli Lilly headquarters — Kristoffer Tripplaar/AP

Eventually, the luckiest companies get to deal with a very particular problem: what to do when their stock could be getting ahead of itself.

It’s a problem Eli Lilly got a little taste of Tuesday when it announced its full-year earnings. The drugmaker’s stock has more than doubled over the past 12 months due to the ever-increasing hopes for its GLP-1-based diabetes and weight loss drug, sold under the brand names Mounjaro and Zepbound. It was a big deal when Lilly became the first drug company ever to have a market value of $500 billion; it’s now sitting at a stunning $670 billion.

At first, the earnings report suggested the company had blasted through expectations again, announcing fourth-quarter 2023 sales of $9.35 billion, almost half a billion dollars above analysts’ expectations, and also announcing new data for Mounjaro in treating metabolic dysfunction-associated steatohepatitis (MASH), a form of liver disease previously called NASH. Initially, shares traded up 5%.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： VC firm General Catalyst wants to buy a health system

knowledge

WSS

Why Charlie Gard's case is so disturbing to Americans

Senate panel eyes new effort on drug shortages

Bill would stop addiction treatment from triggering child abuse inquiry

UnitedHealth wins $3.3 billion takeover of Amedisys

Medical experts exlpore how to eliminate bias in clinical algorithms

Illumina to lay off 10% of research and development team

hotspot

Wikipedia

entertainment

Duchenne breakthrough therapy leaves behind pioneering families

Histogen: Failed biotech offers rare public look inside

How one medical school became remarkably diverse

The sun may be out, but guns are not. A lawsuit challenges a new gun ban on Hawaii beaches

Walensky prepares to leave CDC — and Congress — behind

Synthetic human embryos? Researchers say term is overblown

Malaria cases in Florida and Texas: Here’s what you need to know

Liquid biopsy for lung cancer is launched by Delfi

How to save PrEP access — and even expand it

FDA panel signals lack of confidence in Amgen cancer drug data

hotspot

AI can decode, harness the power of the humane immune system

Bill would stop addiction treatment from triggering child abuse inquiry

Supreme Court rules employers must be more accommodating of religious observance

Ukrainian soldiers say they owe lives to US

A Q&A with the global head of Boehringer Ingelheim's innovation unit

Bill would stop addiction treatment from triggering child abuse inquiry

hotspot

knowledge

hotspot

leisure time